Aster DM Quality Care Ltd
Complete IPO details, including price band, financials, subscription status, and key insights.
Participate in the Aster DM Quality Care Ltd IPO with full transparency. Review issue details, company fundamentals, and financial performance, and apply securely through Alice Blue.
Financial Performance
Revenue, profit after tax and total assets across the last 3 reported financial years.
Revenue
Amount in ₹ crore
Profit After Tax (PAT)
Amount in ₹ crore
Total Assets
Amount in ₹ crore
Figures in ₹ crore, on a consolidated basis, as reported for FY24 to FY26.
Objects of the Issue
How the company plans to utilize IPO proceeds.
Use of Proceeds
The funds raised through this IPO will be used for:
Public offer of 51,586,145* equity shares of face value of Rs.10 each ("equity shares") of Aster DM Healthcare Limited ("company" or "issuer") for cash at a price of Rs.190 per equity share (including a share premium of Rs.180 per equity share) aggregating to Rs.980.14* Crores ("offer") comprising a fresh issue of 38,157,894 equity shares aggregating to Rs.725 crores ("fresh issue") and an offer for sale of 13,428,251 equity shares by the promoter, Union Investments Private limited ("uipl" or the "selling shareholder") aggregating to Rs.255.10 Crores ("offer for sale"). The offer will constitute 10.20%* of the post-offer paid-up equity share capital. The face value of the equity shares is Rs.10 each. The offer price is Rs.190 per equity share and is 19 times the face value of the equity shares. *subject to finalization of basis of allotment
*Subject to approvals and market conditions.
Strengths & Risks
Key competitive advantages and factors to consider before investing.
- Company's ownership structure in most of the GCC states is subject to risks associated with foreign ownership restrictions and the shareholder arrangements with local shareholders might be violative of the local laws of the jurisdictions.
- Certain licenses required to operate Company's businesses in the GCC may be held to contravene legal requirements.
- Certain nominee arrangements lack certain provisions of a protective nature commonly used in similar structures, which may adversely affect Company's business.
- Company's revenue is highly dependent on its operations in the GCC states. Further, its results of operations are, and are expected to continue to be, significantly affected by foreign ownership restrictions, financial, economic and political developments in or affecting the GCC states.
- Company's performance depends on its ability to recruit and retain high quality doctors and other healthcare professionals, such as nurses, pharmacists and technicians.